# A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors

> **NCT04801095** · PHASE1 · UNKNOWN · sponsor: **Wellmarker Bio** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor
- Colorectal Cancer
- Lung Cancer
- Pancreatic Cancer
- Cholangiocarcinoma
- Head and Neck Cancer

## Interventions

- **DRUG:** WM-S1-030

## Key facts

- **NCT ID:** NCT04801095
- **Lead sponsor:** Wellmarker Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-14
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-08-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801095, "A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04801095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*